|
參考文獻
Adams, J.M., Cory, S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene. 2007.
Antignani A, Youle RJ. How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane? Curr Opin Cell Biol. 2006.
Appella E, Anderson CW. Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem. 2001.
Ashkenazi A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer. 2002.
Barnhart BC, Lee JC, Alappat EC, Peter ME. The death effector domain protein family. Oncogene. 2003.
Bartek J, Lukas J. Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol. 2001.
Bouillet, P., Zhang, L.C., Huang, D.C., Webb, G.C., Bottema, C.D., Shore, P., Eyre, H.J., Sutherland, G.R., Adams, J.M.,. Gene structure alternative splicing, and chromosomal localization of pro-apoptotic Bcl-2 relative Bim. Mamm. 2001.
Castedo M, Perfettini JL, Roumier T, Kroemer G. Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe. Cell Death Differ. 2002.
Chen CH, Lo WL, Liu YC, Chen CY. Chemical and cytotoxic constituents from the leaves of Cinnamomum kotoense. J Nat Prod. 2006.
Chinnaiyan AM, O''Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 1995.
Chinoy RF. Proliferative lesions of the breast: carcinoma in situ.Indian J Pathol Microbiol. 2003. Review.
Costantini P, Jacotot E, Decaudin D, Kroemer G. Mitochondrion as a novel target of anticancer chemotherapy. J Natl Cancer Inst. 2000. Review.
Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell. 2004. Review.
Damia G, Broggini M. Improving the selectivity of cancer treatments by interfering with cell response pathways. Eur J Cancer. 2004. Review.
Dumitrescu RG, Cotarla I. Understanding breast cancer risk -- where do we stand in 2005? J Cell Mol Med. 2005.
Eastman A. Cell cycle checkpoints and their impact on anticancer therapeutic strategies.J Cell Biochem. 2004. Review.
Edinger AL, Thompson CB. Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol. 2004. Review.
Esposti MD, Erler JT, Hickman JA, Dive C. Bid, a widely expressed proapoptotic protein of the Bcl-2 family, displays lipid transfer activity. Mol Cell Biol. 2001.
Ewings KE, Wiggins CM, Cook SJ. Bim and the pro-survival Bcl-2 proteins: opposites attract, ERK repels. Cell Cycle. 2007. Review.
Filomeni, G., Aquilano, K., Rotilio, G., Ciriolo, M.R. Glutathione-related systems and modulation of extracellular signal-regulated kinases are involved in the resistance of AGS adenocarcinoma gastric cells to diallyl disulfide-induced apoptosis. Cancer Res. 2005.
Fruehauf JP, Meyskens FL Jr. Reactive oxygen species: a breath of life or death? Clin Cancer Res. 2007. Review.
Fojo T, Coley HM. The role of efflux pumps in drug-resistant metastatic breast cancer: new insights and treatment strategies. Clin Breast Cancer. 2007. Review.
Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther. 2002. Review.
Gary B, Azuero R, Mohanty GS, Bell WC, Eltoum IE, Abdulkadir SA. Interaction of Nkx3.1 and p27/kip1 in prostate tumor initiation. Am J Pathol. 2004.
Genovese C, Trani D, Caputi M, Claudio PP. Cell cycle control and beyond: emerging roles for the retinoblastoma gene family. Oncogene. 2006. Review.
Ghataorhe P, Kurian AW, Pickart A, Trapane P, Norton JA, Kingham K, Ford JM. A carrier of both MEN1 and BRCA2 mutations: case report and review of the literature. Cancer Genet Cytogenet. 2007. Review.
Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol. 2007. Review.
Tavera-Mendoza LE, Wang TT, White JH. p19INK4D and cell death. Cell Cycle. 2006. Review.
Taylor WR, Stark GR. Regulation of the G2/M transition by p53.Oncogene. 2001. Review.
Thorburn A. Death receptor-induced cell killing. Cell Signal. 2004. Review.
Torres M, Forman HJ. Redox signaling and the MAP kinase pathways. Biofactors. 2003. Review.
Torres M. Mitogen-activated protein kinase pathways in redox signaling. Front Biosci. 2003. Review.
Ham YM, Lim JH, Na HK, Choi JS, Park BD, Yim H, Lee SK. Ginsenoside-Rh2-induced mitochondrial depolarization and apoptosis are associated with reactive oxygen species- and Ca2+-mediated c-Jun NH2-terminal kinase 1 activation in HeLa cells. J Pharmacol Exp Ther. 2006.
Harvey SL, Charlet A, Haas W, Gygi SP, Kellogg DR. Cdk1-dependent regulation of the mitotic inhibitor Wee1. Cell. 2005.
Hayakawa J, Depatie C, Ohmichi M, Mercola D. The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair. J Biol Chem. 2003.
Hayashi Y. Mechanism of tumorigenesis caused by tumor suppressor gene. Nippon Rinsho. 2000. Review.
Hengartner MO. The biochemistry of apoptosis. Nature. 2000. Review.
Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, Kinzler KW, Vogelstein B. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell. 1997.
Hsu, Y.L., Kuo, P.L., Lin, L.T., Lin, C.C. Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells. J. Pharmacol. Exp. Ther. 2005.
Inoue M, Sato EF, Nishikawa M, Park AM, Kira Y, Imada I, Utsumi K. Mitochondrial generation of reactive oxygen species and its role in aerobic life. Curr Med Chem. 2003. Review.
Ikegami, T., Matsuzaki, Y., Al Rashid, M., Ceryak, S., Zhang, Y., Bouscarel, B. Enhancement of DNA topoisomerase I inhibitor-induced apoptosis by ursodeoxycholic acid. Mol. Cancer. 2006.
Iwamaru, A., Iwado, E., Kondo, S., Newman, R.A., Vera, B., Rodriguez, A.D., Kondo, Y. Eupalmerin acetate, a novel anticancer agent from Caribbean gorgonian octocorals, induces apoptosis in malignant glioma cells via the c-Jun NH2-terminal kinase pathway. Mol. Cancer Ther. 2007.
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin. 2007.
Jin Z, El-Deiry WS. Overview of cell death signaling pathways. Cancer Biol Ther. 2005. Review.
Johnson GL, Nakamura K. The c-jun kinase/stress-activated pathway: regulation, function and role in human disease. Biochim Biophys Acta. 2007. Review.
Kamata H, Hirata H. Redox regulation of cellular signalling.Cell Signal 1999.
Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature. 2004. Review.
Kaufmann WK. Initiating the uninitiated: replication of damaged DNA and carcinogenesis. Cell Cycle. 2007. Review.
Koreth J, van den Heuvel S. Cell-cycle control in Caenorhabditis elegans: how the worm moves from G1 to S. Oncogene. 2005. Review.
Kelley SK, Ashkenazi A. Targeting death receptors in cancer with Apo2L/TRAIL. Curr Opin Pharmacol. 2004. Review.
Kim BC, Kim HG, Lee SA, Lim S, Park EH, Kim SJ, Lim CJ. Genipin-induced apoptosis in hepatoma cells is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of mitochondrial pathway. Biochem Pharmacol. 2005.
Kim R, Emi M, Tanabe K, Murakami S, Uchida Y, Arihiro K. Regulation and interplay of apoptotic and non-apoptotic cell death. J Pathol. 2006. Review.
Kim SI, Park BW, Lee KS. Comparison of stage-specific outcome of breast cancer based on 5th and 6th AJCC staging system. J Surg Oncol. 2006.
Kinsinger LS, Harris R, Woolf SH, Sox HC, Lohr KN. Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002. Review.
Kirkland RA, Franklin JL. Bax, reactive oxygen, and cytochrome c release in neuronal apoptosis. Antioxid Redox Signal. 2003. Review.
Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity. 2000.
Labi, V., Erlacher, M., Kiessling, S., Villunger, A. BH3-only proteins in cell death initiation, malignant disease and anticancer therapy. Cell Death Differ. 2006.
Lakhani SR, Audretsch W, Cleton-Jensen AM, Cutuli B, Ellis I, Eusebi V, Greco M, Houslton RS, Kuhl CK, Kurtz J, Palacios J, Peterse H, Rochard F, Rutgers E; EUSOMA. The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)? Eur J Cancer. 2006. Review.
Lee JE, Park SS, Han W, Kim SW, Shin HJ, Choe KJ, Oh SK, Youn YK, Noh DY, Kim SW. The clinical use of staging bone scan in patients with breast carcinoma: reevaluation by the 2003 American Joint Committee on Cancer staging system. Cancer. 2005.
Lin A. Activation of the JNK signaling pathway: breaking the brake on apoptosis. Bioessays. 2003. Review.
Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001. Review.
Löbrich M, Jeggo PA. The impact of a negligent G2/M checkpoint on genomic instability and cancer induction. Nat Rev Cancer. 2007. Review.
Lukas, J., Lukas, C. and Bartek, J. Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time. DNA Repair (Amst.). 2004.
Mann J. Natural products in cancer chemotherapy: past, present and future. Nat Rev Cancer. 2002.
McCracken M, Olsen M, Chen MS Jr, Jemal A, Thun M, Cokkinides V, Deapen D, Ward E. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin. 2007. Review.
McCollum, A.K., Teneyck, C.J., Sauer, B.M., Toft, D.O., Erlichman, C. Up-regulation of heat shock protein 27 induces resistance to 17- allylamino- demethoxygeldanamycin through a glutathione-mediated mechanism. Cancer Res. 2006.
Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell. 2003.
Mittler R, Berkowitz G. Hydrogen peroxide, a messenger with too many roles? Redox Rep. 2001. Review.
Moungjaroen J, Nimmannit U, Callery PS, Wang L, Azad N, Lipipun V, Chanvorachote P, Rojanasakul Y. Reactive oxygen species mediate caspase activation and apoptosis induced by lipoic acid in human lung epithelial cancer cells through Bcl-2 down-regulation. J. Pharmacol. Exp. Ther. 2006.
Orrenius S. Mitochondrial regulation of apoptotic cell death. Toxicol Lett. 2004. Review.
Okada H, Mak TW. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer. 2004. Review.
Papa L, Gomes E, Rockwell P. Reactive oxygen species induced by proteasome inhibition in neuronal cells mediate mitochondrial dysfunction and a caspase-independent cell death. Apoptosis. 2007.
Parkin DM, Fernández LM. Use of statistics to assess the global burden of breast cancer. Breast J. 2006. Review.
Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat. 2004.
Pei XH, Xiong Y. Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues. Oncogene. 2005.
Poirier MC. Chemical-induced DNA damage and human cancer risk. Nat Rev Cancer. 2004 Aug;4(8):630-7. Review. No abstract available. Erratum in: Nat Rev Cancer. 2004.
Poon RY, Chau MS, Yamashita K, Hunter T. The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells. Cancer Res. 1997.
Rai R, Peng G, Li K, Lin SY. DNA damage response: the players, the network and the role in tumor suppression. Cancer Genomics Proteomics. 2007. Review.
Ramos, A.M., Fernandez, C., Amran, D., Esteban, D., de Blas, E., Palacios, M.A., Aller, P. Pharmacologic inhibitors of extracellular signal-regulated kinase (ERKs) and c-Jun NH(2)-terminal kinase (JNK) decrease glutathione content and sensitize human promonocytic leukemia cells to arsenic trioxide-induced apoptosis. J. Cell Physiol. 2006..
Rhee SG, Bae YS, Lee SR, Kwon J. Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci STKE. 2000. Review.
Rowinsky EK. Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents. J Clin Oncol. 2005. Review.
Samuel T, Weber HO, Funk JO. Linking DNA damage to cell cycle checkpoints. Cell Cycle. 2002. Review.
Sancar A, Lindsey-Boltz LA, Unsal-Kaçmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem. 2004. Review.
Sander CS, Chang H, Hamm F, Elsner P, Thiele JJ. Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis. Int J Dermatol. 2004. Review.
Sherr CJ, McCormick F. The RB and p53 pathways in cancer. Cancer Cell. 2002.
Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic BiolMed 2001;30:1191-212. Schumacker PT. Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell. 2006.
Schumacker, P.T. Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell. 2006.
Screaton G, Xu XN. T cell life and death signalling via TNF-receptor family members. Curr Opin Immunol. 2000.
Streckfus CF, Mayorga-Wark O, Arreola D, Edwards C, Bigler L, Dubinsky WP. Breast cancer related proteins are present in saliva and are modulated secondary to ductal carcinoma in situ of the breast. Cancer Invest. 2008.
Varfolomeev EE, Ashkenazi A. Tumor necrosis factor: an apoptosis JuNKie? Cell. 2004. Review.
Vidal A, Koff A. Cell-cycle inhibitors: three families united by a common cause. Gene. 2000. Review.
Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L, Hollander MC, O''Connor PM, Fornace AJ Jr, Harris CC. GADD45 induction of a G2/M cell cycle checkpoint.Proc Natl Acad Sci U S A. 1999.
Wajant H. Targeting the FLICE Inhibitory Protein (FLIP) in cancer therapy. Mol Interv. 2003. Review.
White DE, Muller WJ. Multifaceted roles of integrins in breast cancer metastasis. J Mammary Gland Biol Neoplasia. 2007. Review.
Whitmarsh AJ, Davis RJ. Role of mitogen-activated protein kinase kinase 4 in cancer. Oncogene. 2007. Review.
Wooster R, Weber BL. Breast and ovarian cancer. N Engl J Med. 2003. Review.
Wright, S.C., Wang, H., Wei, Q.S., Kinder, D.H., Larrick, J.W. Bcl-2-mediated resistance to apoptosis is associated with glutathione-induced inhibition of AP24 activation of nuclear DNA fragmentation. Cancer Res. 1998.
Wu, W., Pew, T., Zou, M., Pang, D., Conzen, S.D. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival. J Biol Chem. 2005.
Yip, K.W., Li, A., Li, J.H., Shi, W., Chia, M.C., Rashid, S.A., Mocanu, J.D., Louie, A.V., Sanchez, O. Huang, D., Busson, P., Yeh, W.C., Gilbert, R., O''sullivan, B., Gullane, P., Liu, F.F.. Potential utility of BimS as a novel apoptotic therapeutic molecule. Mol. Ther. 2004.
Zhou, J.Y., Liu, Y., Wu, G.S. The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death. Cancer Res. 2006.
|